Fig. 1From: Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancerParticipant flowchart of patients with HIV and concomitant stage II-III colorectal cancer undergoing radical resection and chemotherapy after surgery at the Public Health Clinical Center of Chengdu from January 2020 to November 2021. We excluded 14 patients who did not meet the inclusion criteria. Ultimately, 66 patients (group I: 20, group II: 24, group III: 22) were eligible and enrolled, and none were lost to follow upBack to article page